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Abstract: We have developed a Magnetic Resonance Imaging (MRI)-compatible system 
to enable gating of a scanner to the heartbeat of a foetus for cardiac, umbilical cord flow 
and other possible imaging applications. We performed radiofrequency safety testing prior 
to a fetal electrocardiogram (fECG) gated imaging study in pregnant volunteers (n = 3).  
A compact monitoring device with advanced software capable of reliably detecting both 
the maternal electrocardiogram (mECG) and fECG simultaneously was modified by the 
manufacturer (Monica Healthcare, Nottingham, UK) to provide an external TTL trigger 
signal from the detected fECG which could be used to trigger a standard 1.5 T MR  
(GE Healthcare, Milwaukee, WI, USA) gating system with suitable attenuation. The MR 
scanner was tested by triggering rapidly during image acquisition at a typical fetal heart 
rate (123 beats per minute) using a simulated fECG waveform fed into the gating system. 
Gated MR images were also acquired from volunteers who were attending for a repeat fetal 
Central Nervous System (CNS) examination using an additional rapid cardiac imaging 
sequence triggered from the measured fECG. No adverse safety effects were encountered. 
This is the first time fECG gating has been used with MRI and opens up a range of new 
possibilities to study a developing foetus. 
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1. Introduction 
Triggering of in utero Magnetic Resonance Imaging (iuMRI) by the fetal ECG (fECG) would be 
useful for fetal cardiac studies or flow measurements in the umbilical cord. Currently no manufacturers 
provide the facility to gate to the fECG. The aim of this study was to perform MRI safety tests of a 
fECG sensor modified for MRI triggering capability together with a preliminary in vivo imaging 
feasibility study using the device on pregnant volunteers. 
Real time imaging such as echo planar or single shot fast spin echo imaging can be used to 
effectively freeze fetal motion, but scans are not synchronized to the fetal cardiac cycle and generally 
have worse spatial resolution than can be achieved with gated acquisitions [1–3]. Self-gating, 
navigator-based methods avoid having to detect the fECG by acquiring a signal from the center of  
k-space with each k-space line acquisition, but have varying degrees of success dependent on patient 
motion and other factors [4–8]. Retrospective gating uses continuous acquisition of data together with 
labeling of each acquisition of the cardiac phase at the time of acquisition, but this is only possible 
with an fECG signal. The data is then retrospectively binned and reconstructed resulting in a more 
efficient acquisition strategy and ensuring the data is in steady state at all times throughout the 
acquisition. Metric-optimized gated imaging is a variant on retrospective gating where the ECG signal 
cannot be measured directly. The data are acquired continually over periods longer than the anticipated 
heart beat interval and then assigned to various bins according to a model of the fetal heart rate.  
The ghosting errors which arise in the reconstructed data are then minimized using a measure such as 
time-entropy through an iterative procedure by moving acquired k-space lines between the different 
cardiac cycle intervals [9,10]. 
Ultrasound is an established method for looking at flow in the foetus, placenta and umbilical cord 
providing non-invasive high resolution images with the possible of Doppler velocity imaging and the 
potential to gate an MRI scanner. However, ultrasound can have problems due to acoustic shadowing 
from, for example, bone, which can be a problem in cases with low amniotic fluid levels, maternal 
obesity or with difficult fetal positioning within the uterus. In addition quantitative ultrasound flow 
measurements rely on the shape of the vessels, the insonation angle and the velocity profile which are 
difficult to quantify in a single study [11].  
A modified cardiac triggering device has previously been used to examine the fetal sheep heart [12] 
but in this paper we attempt to use the directly detected human fetal ECG to obviate many of the 
difficulties discussed above and gain access to a full range of gated imaging sequences in terms  
of image contrast and acquisition speed. Combined with maternal breath hold, fECG gating should 
allow cardiac imaging and phase contrast velocity mapping to be acquired from the foetus and 
umbilical cord in future. 
2. Experimental Section  
A compact monitoring device (Figure 1) with advanced software capable of reliably detecting both 
the maternal ECG (mECG) and fECG traces simultaneously was modified by the manufacturer  
(Model AN24, Monica Healthcare, Nottingham, UK) to provide an external TTL trigger signal from 
the detected fECG signal. Six meter long high resistance carbon ECG leads were fed through 
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waveguides into the MR scan room from the device (Figure 2a). The leads were attached to MR 
compatible electrodes and placed on a large torso shaped imaging test object in locations similar to 
those which would be used for fetal gating. The surface of the test object was covered with conducting 
gel as used for the electrodes to provide a circuit for any possible RF pickup (Figure 2b). A single shot 
fast spin echo (SSFSE) sequence was run with the same imaging parameters as used for clinical  
in-utero scanning using the body transmit coil. The radiofrequency voltage generated at 64 MHz was 
measured across the leads using a 100 MHz input bandwidth digital oscilloscope (Tektronix, 
Beaverton, OR, USA).  
Figure 1. Placement of the ECG electrodes on a pregnant volunteer. The electrodes used 
were Ambu Blue Sensor VLC single patient use ECG electrodes (Ambu A/S, Ballerup, 
Denmark) with a skin contact diameter of 68 mm. The skin was gently abraded using a 
dermal abrasive tape (3 M, Bracknell, UK) prior to locating the electrodes. 
 
fECG Monitor Twisted Pair Leads and ECG electrodes positioned on a volunteer  
A waveform file provided by the device manufacturer produced a voltage using the sound card of a 
laptop computer to simulate the mECG and fECG signals. To test gating performance, the fECG signal 
measured through the MR compatible leads was converted into a digital gating pulse which was 
attenuated by 30 db and fed back into the standard MR ECG system. A balanced steady state gradient 
echo FIESTA sequence with SLT = 5 mm, in-plane resolution = 2 mm, NEX = 1, TR/TE = 3.3/1.4 ms 
was acquired with fECG gating at 123 bpm.  
This work was performed with the approval of and under the guidance of the NHS Research Ethics 
Service (reference 10/H1308). All women provided written informed consent prior to their studies. 
Pregnant women (n = 3) with known Central Nervous System (CNS) pathology of their foetus coming 
for a follow up examination (so they already had experience of an MRI examination) were assessed 
using the fetal ECG system. The leads were attached to five MR compatible electrodes and placed on 
the lower abdomen close to the anticipated location of the fetal heart prior to all scanning and presence 
of the fetal trigger pulse checked after patient positioning in the magnet. Images were acquired using a 
1.5 T HDx MR System (GE Healthcare, Milwaukee, WI, USA) using all the sequences included in our 
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standard in-utero CNS imaging protocol plus an additional fECG gated cardiac cine sequence at the 
end of the examination using the same geometry as planned for the CNS examination to comply with 
granted ethical permission. Typical overall in magnet time was 30 min. 
Figure 2. (a) The portable fetal and maternal ECG used for the study (AN24, Monica 
Healthcare, Nottingham, UK). The device records the data into internal memory over long 
periods but also transmits the maternal and fetal ECG data (four channels) in real time over 
a Bluetooth interface. The fECG monitor was connected to the six metre MR compatible 
high resistance leads which go through a waveguide into the scan room. The five leads 
were twisted as a pair and as a triplet. The trigger signal from the device was attenuated by 
30 db and fed back into the scan room using a BNC cable (unfiltered in this case, although 
filtering could be used in future); (b) The leads attached to the MR compatible electrodes 
positioned on a torso phantom on a bed of conducting gel prior to location within the 
magnet for confirmatory safety tests.  
  
(a) (b) 
3. Results and Discussion 
Radiofrequency voltages at 63.9 MHz measured across the leads were always significantly less  
than ±1 V peak to peak using the single shot fast spin echo sequence set up for a 70 kg load which is 
much lower than would produce a radiofrequency burn. The electrodes and test object were relocated 
within the RF body coil four times to assess reproducibility and the same result was observed each 
time. Images were acquired with the electrodes in place using a gradient echo sequence and there was 
no evidence of RF or B0 interference.  
The fECG and mECG signals could be measured in real time using the Bluetooth interface (Figure 3). 
Occasionally, when the fetal and maternal ECG signals coincided, the fetal gating signal was lost  
due to software checks within the device which excluded it during this time. Test object images  
were acquired at the fetal heart rate (123 bpm) to demonstrate the rapid gating capability of the MR 
system (Figure 4). 
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Figure 3. (a) Five maternal cycles of the simulated maternal and fetal ecg waveform used 
for the gating tests. This waveform was played from a PC soundcard and attenuated to the 
peak level expected for maternal in vivo signals (100 μV); (b) Two cycles of the signal 
received over the Bluetooth interface using the six metre, high resistance MR compatible 
leads showing the additional noise introduced. The measured ‘fetal’ signal from the 
simulator measured about 10 μV.  
  
(a) (b) 
Figure 4. A FIESTA sequence with TR = 3.3 ms, TR = 1.4 ms, NEX = 1, in-plane spatial 
resolution = 1 × 1 mm, SLT = 5 mm acquired with the cardiac gating signal from the 
simulated fetal ECG at 123 beats per minute acquired over the 6 m MR compatible leads. 
The images show no artifacts from the leads or electrodes. 
 
Following satisfactory safety testing on test objects, the volunteer study was initiated. No safety 
issues were encountered using the device to record the fECG during fetal imaging on the pregnant 
volunteers. The gating system was present for all imaging sequences. Figure 5 shows raw and Finite 
Impulse Response (FIR)-filtered (4 Hz–45 Hz bandpass provided with the Monica Healthcare 
software) ECG data acquired in the magnet without imaging gradients present clearly showing mECG 
and fECG components at different rates. The mECG was approximately 80 bpm and the fECG was 
approximately 140 bpm for all three volunteers and foetuses. 
Figure 6 illustrates the effects of burst of gradient waveforms from a single shot spin echo sequence 
on the fECG trace. Filtering, as contained in the fECG hardware largely removes the effects of this 
rapid train of pulses. 
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Figure 5. The effects of Finite Impulse Response (FIR) filtering with a standard bandpass filter 
(4–45 Hz) on the combined mECG and fECG signals which were acquired from a volunteer 
within the magnet (without imaging applied). ECG data was recorded during the entire imaging 
session and subsequently downloaded from the device and analysed using a developmental 
software tool from the monitor manufacturer DK V1.5 (Monica Healthcare, Nottingham, UK).  
 
Figure 6. The effects of a single shot fast spin echo sequence gradient burst on the fECG 
trace (upper plot). The effects of a bandpass FIR filter are shown in the lower trace. The 
effects of the gradient pulses are largely removed from the trace but the phase of the ECG 
signal is temporarily altered.  
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Figure 7 show a fECG gated fetal image from one of the volunteers at the end of the normal CNS 
exam using a gradient echo cardiac gated imaging sequence (Right Ventricle Long Axis (RVLA) 
sequence) but using the geometry as planned for the CNS examination.  
Figure 7. A fECG gated rapid image acquired from a foetus in an oblique plane from one 
of the pregnant volunteers. As this feasibility study was performed at the end of a fetal 
CNS pathology examination, it was not possible to specifically plan and visualise the heart 
under ethical guidance. None of the volunteers reported any adverse effects during imaging. 
 
4. Conclusions/Outlook  
Availability of a reliable fetal ECG gating signal should open up a wealth of new opportunities for 
non-invasively measuring the fetal cardio-vascular system. Although self-gating techniques are 
reasonably successful in detecting the cardiac cycle, other MR related issues can modify the detected 
self-gating signal such as approach to steady state, contrast preparation as well as maternal and/or fetal 
bulk motion which can limit the applicability and accuracy.  
In this study it has been demonstrated for the first time that it is possible to safely gate an MR 
scanner to the fECG using a modified fECG monitor and carbon fibre lead system. It was also possible 
to observe the mECG and fECG signals in real-time on a linked computer display using a Bluetooth 
interface available on the fECG device. The fECG signals reliably triggered a fast MR image 
acquisition sequence at the fetal heart rate from the simulated signal at 123 bpm. No interference 
between the gating system and the MR system was observed in terms of generated noise lines on the 
images in these preliminary studies.  
Some gradient interference on the gating signal was observed which occasionally resulted in  
mis-triggering if the fetal gating signal occurred during gradient activity. This was minimized by using 
a short duration data acquisition relative to the fetal ECG period. To improve reliability of fetal 
triggering for longer duration data acquisitions such as used for single shot fast spin echo, improved 
real-time filtering of the ECG signal as demonstrated in Figure 6 could be included in the device 
firmware. In addition, locating the device in the scan room and shortening the twisted pair leads would 
also improve sensitivity and reliability. The device was kept out of the magnet room and long leads 
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were used in this study as the device contained magnetic components which could have lead to a 
projectile hazard and also contained components sensitive to the effects of the RF pulses generated by 
the MR scanner. 
Fetal cardiac gated images were acquired from three pregnant volunteers showing the capability of 
the fetal monitor to operate successfully within the MR environment using extended leads. This should 
provide new opportunities for examining the developing cardiovascular system and umbilical blood 
supply gated to the fetal rather than maternal circulation. This should also allow development of 
quantitative flow protocols through gated velocity phase mapping sequences. 
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